The Lancet Gastroenterology & Hepatology in conversation with
Un pódcast de The Lancet Group
88 Episodo
-
Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
Publicado: 20/11/2025 -
Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
Publicado: 19/6/2025 -
Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
Publicado: 9/4/2025 -
John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer
Publicado: 6/3/2025 -
Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
Publicado: 10/1/2025 -
Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures
Publicado: 12/12/2024 -
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
Publicado: 6/11/2024 -
Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease
Publicado: 1/11/2024 -
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer
Publicado: 31/7/2024 -
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
Publicado: 1/7/2024 -
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
Publicado: 17/5/2024 -
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease
Publicado: 7/5/2024 -
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa
Publicado: 22/4/2024 -
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
Publicado: 12/3/2024 -
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity
Publicado: 1/3/2024 -
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
Publicado: 19/12/2023 -
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
Publicado: 29/11/2023 -
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease
Publicado: 12/10/2023 -
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction
Publicado: 13/9/2023 -
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
Publicado: 10/8/2023
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
